RAP 0.00% 20.5¢ resapp health limited

Ann: Entry into amended and restated Scheme Implementation Deed, page-21

  1. 620 Posts.
    lightbulb Created with Sketch. 93
    I’m always a No - I believe this technology is disruptive . Imagine selling cochlear at 30 cents. On 20 years time this tech that underlies ResApp will be used I believe not only in ResAppdx but many more medical applications. It’s the tech Pfizer want . We should be focused toward partnership not selling the whole house. We are at nest a few years out I believe before the progressive traction compounds into major revenue. Those who sell out will be kicking themselves for taking relative small gains compared to what they would have gained. At best , if you want short term profit - sell on market at the higher price but keep a small parcel and vote No you’ll have nothing to lose but everything to gain if it is the next major disruptor.

    dyor - all my own reasoning and opinion.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.